Biodesix Inc at Canaccord Genuity Growth Conference Transcript
Welcome to the 42nd Annual Canaccord Genuity Global Growth Conference. I'm Kyle Mikson, I cover life science tools and diagnostics for Canaccord. And with us, we have Biodesix. From the company we have Scott Hutton, the company's CEO. And just for background, Biodesix uses multi-omics and AI, artificial intelligence, to create diagnostic solutions for lung disease. Thanks, Scott, for joining us today.
Yes. Thank you, Kyle.
Questions & Answers
So did you want to describe like maybe like an overview of the company? Like, I kind of provided like the high level, but maybe just, how you're using multi-omics, AI to actually address like lung disease?
Yes, it's a great question. We actually focus on a proprietary AI platform that we call the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
